Covered recipient · General Payments record
WENDY M GARLINGTON
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$1,236.13
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $345.52 | 16 |
| Education | $79.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $109.05 | 3 |
| Merck Sharp & Dohme Corporation | $68.22 | 3 |
| Shionogi Inc | $62.45 | 3 |
| ViiV Healthcare Company | $60.11 | 3 |
| ABBVIE INC. | $45.76 | 2 |
| Insmed, Inc. | $31.07 | 1 |
| ConvaTec Inc. | $26.00 | 1 |
| Gilead Sciences, Inc. | $22.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.46 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777239 | CMS |
| ABBVIE INC. | $16.30 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103777241 | CMS |
| Astellas Pharma US Inc | $14.11 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139315752 | CMS |
| Astellas Pharma US Inc | $79.99 | 02/20/2024 | Education | Undisputed | 01/23/2026 | 1139343888 | CMS |
| Astellas Pharma US Inc | $14.95 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139389796 | CMS |
| ConvaTec Inc. | $26.00 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151374110 | CMS |
| Gilead Sciences, Inc. | $22.85 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133815365 | CMS |
| Insmed, Inc. | $31.07 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089570798 | CMS |
| Merck Sharp & Dohme LLC | $22.05 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141850664 | CMS |
| Merck Sharp & Dohme LLC | $19.61 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141645735 | CMS |
| Merck Sharp & Dohme LLC | $26.56 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141647408 | CMS |
| Shionogi Inc | $18.79 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154336792 | CMS |
| Shionogi Inc | $24.11 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154336802 | CMS |
| Shionogi Inc | $19.55 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154336812 | CMS |
| ViiV Healthcare Company | $19.86 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112788112 | CMS |
| ViiV Healthcare Company | $14.92 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112715438 | CMS |
| ViiV Healthcare Company | $25.33 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112701135 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.